Anthem Blue Cross Profits Soar As Patients Postpone Care In Pandemic
Anthem ’s profits doubled to more than $2 billion in the second quarter as elective procedures the large health insurer pays for delayed amid the spread of the Coronavirus strain Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech Editors' Pick editors-pick Coronavirus business pharma Source Type: news

Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
AON-platform with focus on therapies nearing phase I trials for forms of Spinocerebellar Ataxia and Huntington Disease Other early discovery stage RNA editing platform focuses on RETT syndrome Funding led by LSP, co-led by Kurma Partners, supported b... Biopharmaceuticals, Neurology, Venture Capital Vico Therapeutics, RNA modulating therapies (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 29, 2020 Category: Pharmaceuticals Source Type: news

West Penn Hospital approved for expansion for Bloomfield campus through master plan vote
Bloomfield hospital is preparing for an aggressive expansion to near double the number of beds along with a large new garage and medical office space detailed in 10-year master plan (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Tim Schooley Source Type: news

Alisa Haushalter makes final decisions leading pandemic response from Memphis and Shelby County Joint Task Force
Officials from the Shelby County Health Department, the mayors, and medical experts are all part of the task force leading the local response to the pandemic. What is not always clear is: Who is making the final calls? And, what role do the rest play? (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Jacob Steimer Source Type: news

Premature Cardiac Deaths Across U.S. Dropped From 1999 to 2017
WEDNESDAY, July 29, 2020 -- The rate of premature cardiac deaths (PCDs) decreased across U.S. counties from 1999 to 2017, although widening geographic disparities have been observed, according to a study published online July 29 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Cost-Sharing Caps for Insulin Would Benefit Youth With T1D
WEDNESDAY, July 29, 2020 -- For privately insured young children and adults with type 1 diabetes, the mean annual out-of-pocket spending on insulin was $494 in 2018, and many would benefit from price caps, according to a research letter published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Nearly Half of Hispanics, Blacks Scared to Go to Hospital During COVID-19
WEDNESDAY, July 29, 2020 -- Hispanics and blacks are most likely to stay home if experiencing medical emergencies, like a heart attack or stroke, to avoid the risk of contracting COVID-19 at the hospital, according to a poll released by the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Depression, Anxiety May Be Signs That COVID-19 Is Attacking Brain
WEDNESDAY, July 29, 2020 -- Depression and anxiety exhibited in COVID-19 patients may be a sign that the virus impacts the central nervous system, as these symptoms are closely associated with a loss of smell and taste rather than more severe... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Latino Communities at Higher Risk for COVID-19
WEDNESDAY, July 29, 2020 -- Factors linked to structural racism and social determinants of health are associated with an increased risk for COVID-19 in Latino communities, according to a study published online July 23 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Smoking Ups Risk for Unruptured Intracranial Aneurysm in Women
WEDNESDAY, July 29, 2020 -- Women aged 30 to 60 years with a positive smoking history and underlying hypertension have an increased risk for having an unruptured intracranial aneurysm (UIA), according to a study published online July 28 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Obesity in Young Adulthood Tied to Later Venous Thromboembolism
WEDNESDAY, July 29, 2020 -- Men who are obese or severely obese in young adulthood have an increased risk for venous thromboembolism (VTE) later in life, according to a study published in the June issue of the Journal of Internal Medicine. K. Glise... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Low Health Literacy Tied to Worse Heart Failure Outcomes
WEDNESDAY, July 29, 2020 -- Poor health literacy is associated with worse heart failure outcomes, according to a review published in the June issue of JACC: Heart Failure. Matteo Fabbri, M.D., from the Mayo Clinic in Rochester, Minnesota, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Cancer-Related Encounters Down Since Start of COVID-19
WEDNESDAY, July 29, 2020 -- There has been a decrease in cancer-related encounters and in cancer screening since the start of the COVID-19 pandemic, according to a study published online July 27 in JCO: Clinical Cancer Informatics. Jack W. London,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

SGLT-2 Inhibitors May Raise Risk for Diabetic Ketoacidosis
WEDNESDAY, July 29, 2020 -- In patients with type 2 diabetes, sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with an increased risk for diabetic ketoacidosis (DKA), according to a study published online July 28 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 29, 2020 Category: Pharmaceuticals Source Type: news

How Covid-19 Coronavirus May Affect Your Heart, Here Are Two New Studies
Two studies just published in JAMA Cardiology found evidence that the Covid-19 coronavirus can make it to your heart and not in a good way. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick business pharma Source Type: news

Study: How Covid-19 Coronavirus May Affect Your Heart
Two studies just published in JAMA Cardiology found evidence that the Covid-19 coronavirus can make it to your heart and not in a good way. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick business pharma Source Type: news

Humana Buys $100 Million Stake In Doctor House Call Company, Heal
Humana said it is investing $100 million in the in-home primary care company, Heal, to bring in-person physician house calls to seniors in its Medicare Advantage plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Consumer Tech /consumer-tech Editors' Pick editors-pick business pharma Source Type: news

This tech CEO raised a $1M seed round while treating Covid-19 patients, and relying on her own product
With the new funding, investors and a chairman, the company ’s focus is on hiring to build out its staff. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Michelle Caffrey Source Type: news

Humana invests $100 million in health-tech startup Heal, which serves New York
The broad strategic partnership enables Heal to expand to additional markets such as Chicago, Charlotte, Houston and others. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Annlee Ellingson Source Type: news

Humana invests $100 million in L.A. health-tech startup Heal
The broad strategic partnership enables Heal to expand to additional markets such as Chicago, Charlotte, Houston and others. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Annlee Ellingson Source Type: news

Health-tech startup Heal to expand to Chicago after $100 million investment from Humana
The broad strategic partnership enables Heal to expand to additional markets such as Chicago, Charlotte, Houston and others. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Annlee Ellingson Source Type: news

Humana Buys $100 Million Stake In Primary Care House Call Company, Heal
Humana said it is investing $100 million in the in-home primary care company, Heal, to bring in-person physician house calls to seniors in its Medicare Advantage plans. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Consumer Tech /consumer-tech Editors' Pick editors-pick business pharma Source Type: news

Moderna ’s Mysterious Coronavirus Vaccine Delivery System
A preprint of preclinical data for Moderna ’s coronavirus vaccine suggests it uses delivery technology that is covered by a patent owned by Arbutus and upheld last week. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Nathan Vardi, Forbes Staff Tags: Hedge Funds & Private Equity /hedge-funds-private-equity Money /money Innovation /innovation Healthcare /healthcare Editors' Pick editors-pick Decision Maker decision-maker Coronavirus investing Source Type: news

‘World First’ Smart Hand Sanitizer Promises Extra Coronavirus Protection
UK-based tech company SAVORTEX has launched a "revolutionary" smart hand sanitizer, offering an added layer of hygiene against potential coronavirus transmission. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Simon Chandler, Contributor Tags: AI /ai Innovation /innovation Healthcare /healthcare Source Type: news

Hopkins spinoff Thrive Earlier Detection Corp. raises $257 million funding round
Johns Hopkins cancer diagnostics spinoff Thrive Earlier Detection Corp. has raised $257 million in new funding, a little over a year after it closed another huge round. Thrive launched in May 2019 with $110 million in funding for its cancer-detecting blood test developed by researchers at Johns Hopkins. That Series A round was remarkable for its size. It was the largest ever raised in support of a Hopkins-licensed technology, and among the largest raised by any f irm co-based in the Baltimore area.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Morgan Eichensehr Source Type: news

Northam issues new Covid-19 rules for Hampton Roads, warns other areas could follow
Virginia Gov. Ralph Northam on Tuesday announced new health and safety restrictions focused on the Hampton Roads area, which has seen a sharp increase in Covid-19 cases in recent weeks. The governor's order goes into effect at midnight Thursday and calls for no alcohol sales or on-site consumption in restaurants after 10 p.m., the closure of all restaurants at midnight and a return to a limit of 50% capacity for indoor dining. The order also limits gatherings in the region to 50, down from the… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Drew Hansen Source Type: news

Durham biotech uses new funding to acquire gene therapy for eye disease
A Hatteras backed early stage life science company has used its new funding to acquire the exclusive rights to a gene therapy platform targeting eye disease. On Wednesday, Durham-based Atsena Therapeutics announced that it has acquired the exclusive rights to a gene therapy from French pharma giant Sanofi. The therapy targets GUCY2D-associated Leber congenital amaurosis (LCA1) – a genetic eye disease that affects the retina and is a leading cause of blindness in children. The acquisition follows… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Seth Thomas Gulledge Source Type: news

States Scramble To Deal With The Compounding Covid And Opioid Epidemic
Not only does the current pandemic make overdosing more likely but also people with substance use disorder are especially susceptible to Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: Misha Gajewski, Contributor Tags: Healthcare /healthcare Innovation /innovation Lifestyle /lifestyle Vices /vices Source Type: news

New investors boost cancer blood-testing firm ’s $257M Series B round
A Cambridge startup developing a blood test to better detect early cancer has raised new venture capital funding as it mulls an early product launch.   Thrive Earlier Detection Corp. raised $257 million in new financing this week. At least 11 new investors, including Bain Capital Life Sciences, contributed to the Series B funding round alongside existing investors. Thrive launched early last year with $110 million in Series A funding, which wa s one of the biggest Series A rounds at the time (a… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 29, 2020 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Big Pharma, Big Tech and Big Media are waging an all-out WAR against humanity, and their goal is to mass murder as many human beings as possible before they are stopped
(Natural News) Big Tech, Big Pharma and Big Media are now actively colluding to silence all doctors, websites, videos and online content that explains why hydroxychloroquine can save lives and end the coronavirus pandemic in mere weeks. Over the last few days, Big Tech and Big Media conspired to censor all videos of “America’s Frontline... (Source: NaturalNews.com)
Source: NaturalNews.com - July 29, 2020 Category: Consumer Health News Source Type: news

US entitlement reform is urgently needed
Trust funds for Social Security and Medicare are running dry because of the pandemic (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

India ’s Covid-19 Fallout Collides With A Shaky Economy
The second-most populous nation has its work cut out to deal with a surge in domestic infections and global turmoil. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 29, 2020 Category: Pharmaceuticals Authors: William Pesek, Senior Contributor Tags: Asia /asia Business /business Policy /policy Innovation /innovation Healthcare /healthcare Money /money Markets /markets Editors' Pick editors-pick Source Type: news

Covid truths BANNED and CENSORED by Big Pharma
(Natural News) Everybody has a million questions they would love answered, but the so-called “experts” at the CDC, FDA and state governors’ offices don’t seem to have even one single answer that makes sense. All we see are haphazard rules and regulations you must follow or be destroyed. Well, America’s front line doctors aren’t having... (Source: NaturalNews.com)
Source: NaturalNews.com - July 29, 2020 Category: Consumer Health News Source Type: news

Over half of Mumbai slum dwellers have had Covid-19, study claims
Findings suggest spread of coronavirus in India could be much worse than thought (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

Immunoprotein impairs Sars-Cov-2
A protein produced by the human immune system can strongly inhibit corona viruses, including Sars-Cov-2, the pathogen causing Covid-19. An international team from Germany, Switzerland and the USA successfully showed that the LY6E-Protein prevents coronaviruses from causing an infection. (Source: World Pharma News)
Source: World Pharma News - July 29, 2020 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

UK strikes deal for 60m Covid-19 vaccine doses with Sanofi and GSK
Advance purchase agreement depends on clinical trials starting in September (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia
Basel, 29 July - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III COVACTA study of Actemra ®/RoActemra® (tocilizumab) did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe COVID-19 associated pneumonia. In addition, the key secondary endpoints, which included the difference in patient mortality at week four, were not met; however, there was a positive trend in time to hospital discharge in patients treated with Actemra/RoActemra. The COVACTA study did not identify any new safety signals for Actemra/RoActemra. Further analysis of the trial resul...
Source: Roche Investor Update - July 29, 2020 Category: Pharmaceuticals Source Type: news

Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia
Basel, 29 July - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III COVACTA study of Actemra ®/RoActemra® (tocilizumab) did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe COVID-19 associated pneumonia. In addition, the key secondary endpoints, which included the difference in patient mortality at week four, were not met; however, there was a positive trend in time to hospital discharge in patients treated with Actemra/RoActemra. The COVACTA study did not identify any new safety signals for Actemra/RoActemra. Further analysis of the trial resul...
Source: Roche Media News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 hastens French push to bring home medicines manufacture
President Macron says state is prepared to invest in reshoring, starting with paracetamol (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

‘Silver bullet’ to beat Covid-19 unlikely, warns UK vaccine chief
Kate Bingham of government task force plays down hopes of lifetime immunity despite recent positive trial results (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

Trump defends hydroxychloroquine after sharing viral video
A week after apparent reset, president complains about popularity of top public health official (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

SentryHealth Partners with Prescient Medicine to Offer Pharmacogenetic...
The Prescient Medicine LifeKit PreScript will enhance SentryHealth’s WellOnMyWay health and wellness program.(PRWeb July 29, 2020)Read the full story at https://www.prweb.com/releases/sentryhealth_partners_with_prescient_medicine_to_offer_pharmacogenetic_testing/prweb17287831.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 29, 2020 Category: Pharmaceuticals Source Type: news

easyMedicare.com Launches Theismann Medicare Campaign
NFL icon shares his experience using the digital insurance marketplace.(PRWeb July 29, 2020)Read the full story at https://www.prweb.com/releases/easymedicare_com_launches_theismann_medicare_campaign/prweb17288382.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 29, 2020 Category: Pharmaceuticals Source Type: news

G-CON Manufacturing Updates Its Identity to BUILDING FOR LIFE ™
BUILDING FOR LIFE embodies the Company’s commitment to customers’ efforts to provide patients with life improving and lifesaving therapies.(PRWeb July 29, 2020)Read the full story at https://www.prweb.com/releases/g_con_manufacturing_updates_its_identity_to_building_for_life/prweb17288378.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 29, 2020 Category: Pharmaceuticals Source Type: news

BioFactura Awarded $1 Million SBIR Contract for Development of a...
Contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense of the Department of Defense(PRWeb July 29, 2020)Read the full story at https://www.prweb.com/releases/biofactura_awarded_1_million_sbir_contract_for_development_of_a_marburg_virus_therapeutic/prweb17290427.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 29, 2020 Category: Pharmaceuticals Source Type: news

Sanare Bioscience, a New Pharmaceutical R & D Firm, Aims to Improve...
A new pharmaceutical research and design firm, Sanare Bioscience, launches with a mission to improve patient outcomes through innovation.(PRWeb July 29, 2020)Read the full story at https://www.prweb.com/releases/sanare_bioscience_a_new_pharmaceutical_r_d_firm_aims_to_improve_patient_outcomes_with_innovative_approaches/prweb17289338.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 29, 2020 Category: Pharmaceuticals Source Type: news

Care homes in England ‘thrown to the wolves’ during pandemic
Government approach during crisis ‘inconsistent and at times negligent’, parliamentary committee finds (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 29, 2020 Category: Pharmaceuticals Source Type: news

Hetero launches Favipiravir in India under the brand ‘Favivir’ to treat Covid-19
This is the second drug developed by Hetero after Covifor, the generic version of Remdesivir injection to be administered intravenously in a hospital for treatment of severe Covid-19, under the license from Gilead Sciences. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2020 Category: Pharmaceuticals Source Type: news

COVID-19 fatality rate declining progressively, total recoveries 9.88 lakh: Health ministry
India's COVID-19 case fatality rate (CFR) is lower than what it is globally. On Wednesday, the CFR stood at 2.23 per cent, the lowest since April 1, the health ministry said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2020 Category: Pharmaceuticals Source Type: news

Healthcare organization across the spectrum are scaling up operations: ETILC Members
As the country moves towards opening up more, and lockdowns become more local in nature - there is a multi-prong approach being taken towards recovery. Operations are being scaled up in firms that work across the spectrum - diagnostic firms are releasing more efficient and speedy tests, pharma companies are testing more drugs and hospitals are looking at effective management. (Source: The Economic Times)
Source: The Economic Times - July 29, 2020 Category: Consumer Health News Source Type: news